Risk and Return in the Pharmaceutical Industry

Nick Marchant

Monograph from Office of Health Economics

Abstract: This book has been built up from the papers delivered at the Office of Health Economics conference which took place at the Langham Hilton Hotel, London, on 5 December 1996. The speakers assembled for this symposium represent important contributors to the economic analysis of the risks inherent in pharmaceutical research and development (R&D) and the returns achieved by it. Together these authors bring to this analysis a unique combination of academic rigour and detailed knowledge of industry practice. The result is a series of telling insights into the peculiar characteristics of the risk/return trade-offs intrinsic to R&D in the pharmaceutical industry.

Keywords: Risk; and; Return; in; the; Pharmaceutical; Industry (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 1999-08-01
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.ohe.org/publications/risk-and-return-p ... k_and_return_sussex/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:monogr:000453

Access Statistics for this paper

More papers in Monograph from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).